Article History
Received: 10 January 2018
Accepted: 9 April 2018
First Online: 13 April 2018
Compliance with ethical standards
:
: The study sponsor (Novartis) shared access to the primary data of the COMPARZ study but was not involved in concept, design, conduct, or analysis of the data. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
: Viktor Grünwald has an advisory role at Pfizer, Novartis, Bristol Myer Squibb, Ipsen, Eisai, Roche and has received honoraria from Pfizer, Novartis, Bristol Myer Squibb, Ipsen, Eisai and Roche. Marion Dietrich and Gregory Pond do not have any conflict of interest.